Responses to SARS-CoV-2 Vaccination in Patients with Cancer (ReCOVer Study): A Prospective Cohort Study of the Hellenic Cooperative Oncology Group

SIMPLE SUMMARY: There is limited information on the safety and efficacy of approved SARS-CoV-2 vaccines in cancer patients, as they were excluded from registration vaccine trials. We investigated the humoral immunity post SARS-CoV-2 vaccination in cancer patients compared to healthy volunteers. In t...

Descripción completa

Detalles Bibliográficos
Autores principales: Linardou, Helena, Spanakis, Nikolaos, Koliou, Georgia-Angeliki, Christopoulou, Athina, Karageorgopoulou, Sofia, Alevra, Nephely, Vagionas, Anastasios, Tsoukalas, Nikolaos, Sgourou, Stavroula, Fountzilas, Elena, Sgouros, Joseph, Razis, Evangelia, Chatzokou, Dimitra, Lampaki, Sofia, Res, Eleni, Saridaki, Zacharenia, Mountzios, Giannis, Saroglou, George, Fountzilas, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466969/
https://www.ncbi.nlm.nih.gov/pubmed/34572848
http://dx.doi.org/10.3390/cancers13184621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466969/
https://www.ncbi.nlm.nih.gov/pubmed/34572848
http://dx.doi.org/10.3390/cancers13184621

Ejemplares similares